Teresa Briggs Sells 365 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) Director Teresa Briggs sold 365 shares of Docusign stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $69.19, for a total value of $25,254.35. Following the transaction, the director owned 8,805 shares of the company’s stock, valued at $609,217.95. The trade was a 3.98% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Teresa Briggs also recently made the following trade(s):

• On Thursday, September 11th, Teresa Briggs sold 364 shares of Docusign stock. The stock was sold at an average price of $79.39, for a total value of $28,897.96.

Docusign Stock Performance

Docusign stock traded up $0.53 during midday trading on Tuesday, hitting $68.86. 2,698,883 shares of the company were exchanged, compared to its average volume of 1,792,943. The business has a fifty day simple moving average of $70.59 and a two-hundred day simple moving average of $75.68. The firm has a market capitalization of $13.85 billion, a PE ratio of 51.76, a price-to-earnings-growth ratio of 3.40 and a beta of 0.98. Docusign Inc. has a fifty-two week low of $63.50 and a fifty-two week high of $107.86.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. The business had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The business’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.97 EPS. As a group, equities analysts expect that Docusign Inc. will post 1.17 earnings per share for the current year.

Hedge Funds Weigh In On Docusign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Banque Transatlantique SA acquired a new stake in shares of Docusign in the first quarter valued at about $26,000. Hemington Wealth Management lifted its stake in Docusign by 318.1% in the 1st quarter. Hemington Wealth Management now owns 347 shares of the company’s stock valued at $28,000 after buying an additional 264 shares in the last quarter. Summit Securities Group LLC purchased a new position in Docusign in the 1st quarter valued at about $34,000. Rise Advisors LLC boosted its holdings in Docusign by 864.6% in the 1st quarter. Rise Advisors LLC now owns 463 shares of the company’s stock worth $38,000 after buying an additional 415 shares during the last quarter. Finally, WPG Advisers LLC acquired a new stake in Docusign in the 1st quarter worth about $39,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DOCU. Zacks Research downgraded shares of Docusign from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. JPMorgan Chase & Co. upped their price objective on shares of Docusign from $77.00 to $80.00 and gave the stock a “neutral” rating in a research report on Friday, September 5th. Wells Fargo & Company increased their target price on shares of Docusign from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Friday, September 5th. Royal Bank Of Canada lifted their price target on Docusign from $90.00 to $95.00 and gave the company a “sector perform” rating in a research note on Friday, September 5th. Finally, Bank of America upped their price target on Docusign from $85.00 to $102.00 and gave the stock a “neutral” rating in a report on Friday, September 5th. Four analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $94.14.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.